InterStim Therapy is a sacral neuromodulation therapy from Medtronic. InterStim has been regularly used for urinary incontinence for more than a decade, but recently received additional approval as ...

InterStim Therapy for Bowel Control Recently Approved by the U.S. FDA MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) announced today that newly published data from a multicenter, ...

InterStim therapy is an implanted stopwatch-sized device that acts as a 'pacemaker' by determining the rate of firing of the muscles in the pelvic floor and can change the way the bladder and ...

Another holiday season and Andrea had turned down numerous invitations again this year, trapped in her own home by urinary incontinence — or loss of bladder control. The leakage from her bladder ...

Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to other non-invasive therapies. The system works by targeting nerve signals that ...

DANVILLE — For people who suffer from sudden urine loss and are not responsive to drug therapies or lifestyle changes, there is another option that can provide relief from this disconcerting disorder.

Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence InterStim Micro is a ...

One of the world’s largest medical technology, services and solutions companies, Medtronic plc MDT is making efforts to expand its Pelvic Health & Gastric Therapies business, part of the company's ...

Medtronic plc’s MDT Verify Evaluation System recently won the U.S. Food and Drug Administration (FDA) approval for the device’s expanded use in basic evaluation of patients treated with Medtronic’s ...

Medtronic’s MDT neuromodulation business advanced recently with the company receiving FDA’s expanded MRI labeling approval for its InterStim line of sacral neuromodulation (SNM) systems. The updated ...